Regulation of retinoblastoma gene expression in a mouse mammary tumor model.

E. G. Hanania, W. W. Au, R. L. Ullrich, John Papaconstantinou

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We initiated studies to investigate the involvement of the murine retinoblastoma (RB) gene in mammary carcinogenesis using cell lines derived from mammary glands of irradiated mice. We found that the RB mRNA levels as well as the amounts of the nuclear phosphoprotein were significantly reduced as the cells progressed in vitro from non-tumorigenic to tumorigenic stages. To further investigate RB gene expression with cellular development and tumorigenicity, we transfected malignant cells with expression vectors containing the murine RB cDNA driven by either the SV40 or the mouse metallothionein promoter sequences. The neomycin resistant gene was included in both vectors and was used as a selective marker for the transfected cells. Cells with reduced levels of endogenous RB mRNA were stably transfected and showed increased expression of RB. In addition, the morphology of these cells were altered and their growth rates in culture were reduced. Injection of the transfected cells into host mice resulted in a delayed onset of tumors compared with nontransfected parental cells. Our studies provide experimental data to confirm that loss of RB gene activity is involved in neoplastic transformation of cells and support the multistep theory of carcinogenesis.

Original languageEnglish (US)
Pages (from-to)251-261
Number of pages11
JournalCancer Gene Therapy
Volume2
Issue number4
StatePublished - Dec 1995

Fingerprint

Retinoblastoma Genes
Gene Expression Regulation
Breast Neoplasms
Retinoblastoma
Carcinogenesis
Neoplastic Cell Transformation
Messenger RNA
Neomycin
Metallothionein
Phosphoproteins
Human Mammary Glands
Breast
Complementary DNA
Gene Expression
Cell Line
Injections
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Regulation of retinoblastoma gene expression in a mouse mammary tumor model. / Hanania, E. G.; Au, W. W.; Ullrich, R. L.; Papaconstantinou, John.

In: Cancer Gene Therapy, Vol. 2, No. 4, 12.1995, p. 251-261.

Research output: Contribution to journalArticle

Hanania, E. G. ; Au, W. W. ; Ullrich, R. L. ; Papaconstantinou, John. / Regulation of retinoblastoma gene expression in a mouse mammary tumor model. In: Cancer Gene Therapy. 1995 ; Vol. 2, No. 4. pp. 251-261.
@article{fd914950a91d42ebb1d190f154ccf4cb,
title = "Regulation of retinoblastoma gene expression in a mouse mammary tumor model.",
abstract = "We initiated studies to investigate the involvement of the murine retinoblastoma (RB) gene in mammary carcinogenesis using cell lines derived from mammary glands of irradiated mice. We found that the RB mRNA levels as well as the amounts of the nuclear phosphoprotein were significantly reduced as the cells progressed in vitro from non-tumorigenic to tumorigenic stages. To further investigate RB gene expression with cellular development and tumorigenicity, we transfected malignant cells with expression vectors containing the murine RB cDNA driven by either the SV40 or the mouse metallothionein promoter sequences. The neomycin resistant gene was included in both vectors and was used as a selective marker for the transfected cells. Cells with reduced levels of endogenous RB mRNA were stably transfected and showed increased expression of RB. In addition, the morphology of these cells were altered and their growth rates in culture were reduced. Injection of the transfected cells into host mice resulted in a delayed onset of tumors compared with nontransfected parental cells. Our studies provide experimental data to confirm that loss of RB gene activity is involved in neoplastic transformation of cells and support the multistep theory of carcinogenesis.",
author = "Hanania, {E. G.} and Au, {W. W.} and Ullrich, {R. L.} and John Papaconstantinou",
year = "1995",
month = "12",
language = "English (US)",
volume = "2",
pages = "251--261",
journal = "Cancer Gene Therapy",
issn = "0929-1903",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Regulation of retinoblastoma gene expression in a mouse mammary tumor model.

AU - Hanania, E. G.

AU - Au, W. W.

AU - Ullrich, R. L.

AU - Papaconstantinou, John

PY - 1995/12

Y1 - 1995/12

N2 - We initiated studies to investigate the involvement of the murine retinoblastoma (RB) gene in mammary carcinogenesis using cell lines derived from mammary glands of irradiated mice. We found that the RB mRNA levels as well as the amounts of the nuclear phosphoprotein were significantly reduced as the cells progressed in vitro from non-tumorigenic to tumorigenic stages. To further investigate RB gene expression with cellular development and tumorigenicity, we transfected malignant cells with expression vectors containing the murine RB cDNA driven by either the SV40 or the mouse metallothionein promoter sequences. The neomycin resistant gene was included in both vectors and was used as a selective marker for the transfected cells. Cells with reduced levels of endogenous RB mRNA were stably transfected and showed increased expression of RB. In addition, the morphology of these cells were altered and their growth rates in culture were reduced. Injection of the transfected cells into host mice resulted in a delayed onset of tumors compared with nontransfected parental cells. Our studies provide experimental data to confirm that loss of RB gene activity is involved in neoplastic transformation of cells and support the multistep theory of carcinogenesis.

AB - We initiated studies to investigate the involvement of the murine retinoblastoma (RB) gene in mammary carcinogenesis using cell lines derived from mammary glands of irradiated mice. We found that the RB mRNA levels as well as the amounts of the nuclear phosphoprotein were significantly reduced as the cells progressed in vitro from non-tumorigenic to tumorigenic stages. To further investigate RB gene expression with cellular development and tumorigenicity, we transfected malignant cells with expression vectors containing the murine RB cDNA driven by either the SV40 or the mouse metallothionein promoter sequences. The neomycin resistant gene was included in both vectors and was used as a selective marker for the transfected cells. Cells with reduced levels of endogenous RB mRNA were stably transfected and showed increased expression of RB. In addition, the morphology of these cells were altered and their growth rates in culture were reduced. Injection of the transfected cells into host mice resulted in a delayed onset of tumors compared with nontransfected parental cells. Our studies provide experimental data to confirm that loss of RB gene activity is involved in neoplastic transformation of cells and support the multistep theory of carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0029438005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029438005&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 251

EP - 261

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

SN - 0929-1903

IS - 4

ER -